Monthly subscription
$125/month
One-time order
$140 advertised
Difference per purchase
$15 at displayed prices
Delivery
Free discreet shipping advertised
Assessment
Online prescription evaluation required

Two payment choices for one format

AgelessRx presents its NAD+ nasal spray with a $125 monthly subscription and a $140 one-time option. That is a useful distinction for someone who wants to understand the financial commitment before choosing a recurring plan. At the displayed prices, the subscription is $15 less per purchase, but the comparison assumes the same prescribed product and quantity.

A one-time order may reduce the administrative task of stopping a renewal. It does not establish that a single order is a clinically appropriate trial or that the prescription should be used without follow-up. The clinician should determine that part of the plan.

The annual arithmetic has conditions

Twelve unchanged monthly charges of $125 would total $1,500. Twelve separate $140 orders would total $1,680. These are purchasing scenarios, not advice to use the product for a year or verified forecasts of future prices. They also assume one comparable order per month; a different prescription or refill schedule changes the calculation.

Before comparing those totals, confirm bottle size, formulation and whether the one-time and subscription options include the same clinical support. A price difference is easiest to interpret when the underlying service is genuinely the same.

Why we leave the current bottle size open

Older official shopping material describes a particular bottle specification, while the current primary product page emphasizes the plan and clinical process. We do not silently carry a legacy container size into the current listing. The appropriate quantity for a live quote is the one confirmed for the product now being dispensed.

Ask for volume, concentration, pump information and the applicable storage instructions. These details can change the practical experience and the usefulness of a price-per-volume comparison. The exact pharmacy label should be checked against the order when it arrives.

A nasal mechanism is not an outcome guarantee

AgelessRx discusses targeted intranasal delivery and cognitive goals. The page also presents a customer survey. Neither route language nor reported satisfaction establishes that the spray prevents dementia, clears brain pathology or reliably improves concentration in an individual. We do not convert those marketing statements into product-review findings.

Ask the clinician which evidence concerns the actual nasal preparation and which comes from animals, laboratory models, oral precursors or a different route. That question is especially useful when a page places mechanistic illustrations beside day-by-day expectations, because the illustration may look more certain than the relevant clinical data.

When this offer is easiest to assess

This entry is most straightforward when a patient already has a clinician-approved nasal plan and wants to compare a recurring order with a one-time purchase. Verify the renewal date, processing cutoff and whether a pause preserves the existing prescription or requires another assessment. A subscription setting is an operational feature, not a medical instruction.

The page advertises free shipping and continuing support, which should be reconciled with the final checkout summary. Keep that summary and the pharmacy's directions together. Our comparison addresses published terms; it does not report personal testing, certify product quality or establish that a nasal route is preferable to an injection.

Useful distinctions

  • One-time and subscription prices are both visible
  • Simple $15 purchase-price difference
  • Free delivery advertised

Limitations to weigh

  • Current bottle specification needs confirmation
  • Annual figures are scenarios rather than treatment recommendations
  • Cognitive claims and surveys do not establish causal benefit

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. AgelessRx NAD+ Nasal Spray Provider
  2. FDA: Compounding questions and answers Regulator
  3. Grant et al. 2019: Human plasma and urine metabolome during NAD+ IV infusion Clinical research